Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 10/2112 | 28/18670 | 0.000643 | 0.005838 | 0.004218 | 10 | RABC51 | |
BP | GO:0045017 | glycerolipid biosynthetic process | 46/2112 | 251/18670 | 0.0006472 | 0.005868 | 0.00424 | 46 | RABC51 | |
BP | GO:0009612 | response to mechanical stimulus | 40/2112 | 210/18670 | 0.0006502 | 0.005886 | 0.004253 | 40 | RABC51 | |
BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 20/2112 | 82/18670 | 0.0006539 | 0.005911 | 0.004271 | 20 | RABC51 | |
BP | GO:0032868 | response to insulin | 49/2112 | 272/18670 | 0.0006566 | 0.005916 | 0.004275 | 49 | RABC51 | |
BP | GO:0051403 | stress-activated MAPK cascade | 51/2112 | 286/18670 | 0.000657 | 0.005916 | 0.004275 | 51 | RABC51 | |
BP | GO:0000082 | G1/S transition of mitotic cell cycle | 50/2112 | 279/18670 | 0.0006574 | 0.005916 | 0.004275 | 50 | RABC51 | |
BP | GO:0034103 | regulation of tissue remodeling | 21/2112 | 88/18670 | 0.0006615 | 0.005941 | 0.004292 | 21 | RABC51 | |
BP | GO:0046851 | negative regulation of bone remodeling | 7/2112 | 15/18670 | 0.000662 | 0.005941 | 0.004292 | 7 | RABC51 | |
BP | GO:0042088 | T-helper 1 type immune response | 13/2112 | 43/18670 | 0.000663 | 0.005941 | 0.004292 | 13 | RABC51 | |
BP | GO:0001914 | regulation of T cell mediated cytotoxicity | 11/2112 | 33/18670 | 0.0006833 | 0.006088 | 0.004399 | 11 | RABC51 | |
BP | GO:0002717 | positive regulation of natural killer cell mediated immunity | 11/2112 | 33/18670 | 0.0006833 | 0.006088 | 0.004399 | 11 | RABC51 | |
BP | GO:0010464 | regulation of mesenchymal cell proliferation | 11/2112 | 33/18670 | 0.0006833 | 0.006088 | 0.004399 | 11 | RABC51 | |
BP | GO:0030851 | granulocyte differentiation | 11/2112 | 33/18670 | 0.0006833 | 0.006088 | 0.004399 | 11 | RABC51 | |
BP | GO:0051048 | negative regulation of secretion | 44/2112 | 238/18670 | 0.0006947 | 0.00617 | 0.004458 | 44 | RABC51 | |
BP | GO:0072577 | endothelial cell apoptotic process | 17/2112 | 65/18670 | 0.0006952 | 0.00617 | 0.004458 | 17 | RABC51 | |
BP | GO:0061008 | hepaticobiliary system development | 29/2112 | 138/18670 | 0.0006955 | 0.00617 | 0.004458 | 29 | RABC51 | |
BP | GO:0001952 | regulation of cell-matrix adhesion | 26/2112 | 119/18670 | 0.0006978 | 0.006181 | 0.004466 | 26 | RABC51 | |
BP | GO:0044839 | cell cycle G2/M phase transition | 48/2112 | 266/18670 | 0.0007131 | 0.006308 | 0.004557 | 48 | RABC51 | |
BP | GO:0044786 | cell cycle DNA replication | 18/2112 | 71/18670 | 0.0007331 | 0.006467 | 0.004672 | 18 | RABC51 | |
BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 18/2112 | 71/18670 | 0.0007331 | 0.006467 | 0.004672 | 18 | RABC51 | |
BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 30/2112 | 145/18670 | 0.0007444 | 0.006557 | 0.004737 | 30 | RABC51 | |
BP | GO:0060541 | respiratory system development | 38/2112 | 198/18670 | 0.0007542 | 0.006633 | 0.004793 | 38 | RABC51 | |
BP | GO:0032481 | positive regulation of type I interferon production | 19/2112 | 77/18670 | 0.000758 | 0.006657 | 0.00481 | 19 | RABC51 | |
BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 23/2112 | 101/18670 | 0.0007592 | 0.006657 | 0.00481 | 23 | RABC51 | |
BP | GO:0051402 | neuron apoptotic process | 44/2112 | 239/18670 | 0.0007601 | 0.006657 | 0.00481 | 44 | RABC51 | |
BP | GO:0045010 | actin nucleation | 14/2112 | 49/18670 | 0.0007833 | 0.006851 | 0.00495 | 14 | RABC51 | |
BP | GO:0000187 | activation of MAPK activity | 31/2112 | 152/18670 | 0.00079 | 0.006899 | 0.004985 | 31 | RABC51 | |
BP | GO:0043302 | positive regulation of leukocyte degranulation | 9/2112 | 24/18670 | 0.0007965 | 0.006946 | 0.005019 | 9 | RABC51 | |
BP | GO:0007584 | response to nutrient | 41/2112 | 219/18670 | 0.0008024 | 0.006987 | 0.005049 | 41 | RABC51 |